Molecular and Cellular News

There is more than one way for triple-negative breast cancer to become resistant to therapy -
‘Sticky coat’ boosts triple negative breast cancer’s ability to metastasize -
Finding new cell markers to track the most aggressive breast cancer in blood -
Some p53 mutations could help fight cancer -
Scientists uncover nuclear droplets that link multiple leukemias revealing new therapeutic target -
Unlocking cell identity: RNA sequestration in P-bodies directs cell fate transitions -
TMC collaboration: training new kidney, urologic and hematologic researchers -
Surprising structure discovered in disordered protein -
Single-cell RNA sequencing of bone metastases reveals distinct immune archetypes -
Cell Painting identifies flavonoids that are toxic to bladder cancer cells -
Human placenta stress response to maternal COVID-19 infection reinforces maternal-fetal barrier -
Integrative approach reveals promising candidates for AD risk factors or targets for treatments -
Fatty acids promote immune suppression and therapy resistance in triple negative breast cancer -
New insights into ageing revealed -
Baylor and Rice receive $2.3 million to develop antibody therapy for metastatic breast cancer -
New open-source platform supports large imaging data analysis -
Three Baylor College of Medicine faculty earn NIH Innovator Awards -
Researchers discovered mechanism driving immune perturbations after severe infections -
Tumor-induced B cell changes reveal potential biomarker for treatment response in triple negative breast cancer -
P-bodies sustain acute myeloid leukemia -
hnRNPM, a guardian of the integrity of cellular protein production -
Dr. Hugo Bellen named recipient of the 2024 Gruber Genetics Prize -
A novel switch to turn genes on/off, promising step toward safer gene therapy -
Protein eIF4A emerges as a potential Achilles’ heel for triple-negative breast cancer -
Novel molecule disrupts several molecular pathways that lead to cancer growth -
A novel strategy to suppress triple negative breast cancer growth -
Eliminating gene SRC-3 in immune cells triggers effective long-lasting anti-cancer response -
Delivering on the promise of personalized breast cancer therapy -
Breast cancer tumors disrupt the immune system remotely favoring their own growth -
How a mutation in the SKD3 enzyme can cause MGCA7 disease -